Article
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.
Microbiology spectrum - 23 Feb 2022
Song Jing, Du Weili, Liu Zichen, Che Jialu, Li Kun, Che Nanying
Abstract excerpt
Next-generation sequencing (NGS) enables rapid identification of common and rare drug-resistant genetic variations from tuberculosis (TB) patients' sputum samples and MTB isolates. However, whether this technology is effective for formalin-fixed and paraffin-embedded (FFPE) tissues remains unclear. An amplicon-based targeted NGS sequencing panel was developed to predict susceptibility to 9 antituberculosis drugs,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
